5.2 Clinical Assessment, Diagnostic Imaging & BI-RADS Categorization

Clinical breast assessment begins with a focused health history and thorough physical examination to differentiate physiologic variations from suspicious symptoms requiring urgent diagnostic workup. Breast care nurses play a pivotal role in triaging patient symptoms, coordinating multi-modality diagnostic imaging, and explaining complex radiologic findings to alleviate distress.

Clinical Evaluation of Breast Symptoms

Patients presenting with breast complaints require systematic evaluation of palpable masses, skin changes, nipple alterations, and discharge patterns.

Palpable Breast Masses

A palpable breast mass is the most common presenting symptom of breast disease. Clinical examination evaluates mass size, shape, consistency, mobility, and relationship to surrounding anatomic structures:

• Malignant features: Classically solitary, firm-to-hard, painless, poorly circumscribed with irregular margins, and fixed or tethered to underlying pectoral fascia or overlying skin.
• Benign features: Typically smooth, round or ovoid, soft to rubbery/elastic, well-demarcated, mobile, and frequently tender or fluctuating in size with the menstrual cycle (e.g., simple cysts, fibroadenomas).
• Clinical pearl: Any newly discovered, persistent, dominant solid mass requires diagnostic imaging and tissue sampling regardless of patient age or reassuring physical exam findings, as up to 10% to 15% of breast malignancies are mammographically occult.

Nipple and Areolar Changes

Nipple alterations provide critical clues regarding retroareolar pathology:

• Nipple retraction and inversion: Longstanding congenital nipple inversion is typically bilateral and easily everted with gentle manipulation. In contrast, newly acquired, fixed unilateral nipple retraction or slit-like deviation signifies underlying parenchymal fibrosis or an invasive tumor pulling on retroareolar lactiferous ducts.
• Scaling, crusting, and eczematoid ulceration: Unilateral scaling, persistent erythema, and weeping ulceration of the nipple-areolar complex are classical signs of Paget disease of the nipple. Often misdiagnosed as contact dermatitis or eczema, this condition represents malignant adenocarcinoma cells within the epidermis and is associated with an underlying in situ or invasive malignancy in over 90% of cases.

Skin Changes

Cutaneous manifestations reflect tumor infiltration into superficial lymphatic channels or structural fascial ligaments:

• Skin tethering and dimpling: Desmoplastic stromal reaction surrounding a carcinoma shortens the suspensory retinacula cutis (Cooper's ligaments), resulting in focal skin retraction visible when the patient raises their arms overhead or contracts the pectoralis major muscles.
• Erythema and peau d'orange: Diffuse erythema, cutaneous warmth, and marked dermal edema with exaggerated follicular openings (peau d'orange, resembling orange peel skin) signal obstruction of dermal lymphatic drainage by tumor emboli, the hallmark presentation of inflammatory breast cancer (IBC).

Pathologic vs. Physiologic Nipple Discharge

Nipple discharge accounts for approximately 5% to 7% of outpatient breast referrals. Differentiating benign physiologic secretion from pathologic discharge is essential:

• Pathologic discharge: Unilateral, spontaneous (discharging without external manipulation), persistent, issuing from a solitary duct orifice, and serous, serosanguinous, or frank bloody in appearance. The most frequent cause is a benign solitary intraductal papilloma (50% to 70%), followed by duct ectasia, but underlying ductal carcinoma in situ (DCIS) or invasive carcinoma is identified in 5% to 15% of cases.
• Physiologic discharge: Bilateral, non-spontaneous (elicited only with vigorous manual expression or breast pumping), multi-ductal, and variable in color (milky white, dark green, brownish, or amber). Milky discharge (galactorrhea) stems from hyperprolactinemia, thyroid dysfunction, medications (e.g., antipsychotics, metoclopramide), or chronic chest wall stimulation.

Diagnostic Imaging Modalities

When a clinical abnormality is identified or a screening exam yields an abnormal finding, diagnostic imaging is performed under the direct supervision of a dedicated breast radiologist.

Diagnostic Mammography vs. Screening Mammography

Screening mammography consists of standard bilateral two-view examinations—craniocaudal (CC) and mediolateral oblique (MLO)—performed on asymptomatic individuals. In contrast, diagnostic mammography is tailored to investigate specific signs, symptoms, or screening recalls:

• Spot compression views: Direct focal pressure over an area of concern to displace overlapping glandular parenchyma, determining whether an apparent density represents superimposition or a true three-dimensional parenchymal mass or architectural distortion.
• Magnification views: Performed without a grid using a small focal spot to magnify microcalcifications, allowing precise assessment of their morphology (fine pleomorphic, amorphous, fine linear branching) and spatial distribution (grouped, linear, segmental).
• Tangential views: Profile cutaneous moles, scars, or superficial lesions using radiopaque skin markers to confirm their dermal origin and avoid unnecessary biopsies.

Diagnostic Breast Ultrasound

High-resolution diagnostic ultrasound (using high-frequency linear-array transducers of 12 to 18 MHz) is the initial imaging modality of choice for women under age 30, pregnant or lactating individuals, and as an essential adjunct to mammography for characterization of palpable or mammographically detected abnormalities:

• Cystic vs. solid distinction: Readily distinguishes simple cysts (anechoic, round or oval, smooth thin margins, posterior acoustic enhancement; 0% malignancy risk) from complex cystic and solid masses (thick walls, internal septations, intracystic solid components) and solid lesions.
• Malignant sonographic features: Hypoechoic parenchyma, taller-than-wide orientation (anteroposterior dimension exceeding transverse dimension, indicating growth cutting across normal tissue planes), irregular or spiculated margins, angular or microlobulated contours, marked posterior acoustic shadowing, and internal microvascularity on color Doppler.
• Benign sonographic features: Well-circumscribed margins, oval or round shape, wider-than-tall orientation (parallel to skin), uniform hyperechogenicity, and bilateral edge refraction shadowing.

Diagnostic Breast Magnetic Resonance Imaging (MRI)

Dynamic contrast-enhanced breast MRI with intravenous gadolinium chelate offers high diagnostic sensitivity (exceeding 90% to 95%) by demonstrating tumor-induced neoangiogenesis, characterized by rapid arterial wash-in and delayed wash-out kinetics. Common clinical indications include:

• Occult primary breast carcinoma: Investigating patients presenting with biopsy-proven metastatic adenocarcinoma in axillary lymph nodes when clinical exam, mammography, and ultrasound fail to identify a primary breast tumor (TxN+ disease).
• Extent of disease assessment: Evaluating multifocal, multicentric, or contralateral disease in patients with newly diagnosed invasive lobular carcinoma (ILC), which has a notorious propensity for subtle, diffuse, mammographically occult infiltration.
• Neoadjuvant therapy monitoring: Assessing residual tumor volume and biologic response during and following neoadjuvant systemic therapy to plan breast-conserving surgery.
• Silicone implant integrity: Evaluating suspected intra-capsular rupture (characterized by the "linguine sign" on non-contrast T2-weighted sequences) or extra-capsular silicone extravasation.

The ACR BI-RADS Categorization System

The American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI-RADS) establishes a standardized lexicon and structured assessment categories to guide clinical management.

Nursing Considerations in Diagnostic Assessment

Breast care nurses support patients through the vulnerable diagnostic evaluation window by:

• Alleviating diagnostic anxiety: Reassuring patients that a recall from screening mammography (BI-RADS 0) occurs in approximately 8% to 12% of screening exams and that the vast majority (greater than 90%) result in benign outcomes.
• Patient education: Clarifying the rationale for short-interval imaging in BI-RADS 3 findings versus the necessity of histological sampling for BI-RADS 4 or 5 lesions.
• Care coordination: Ensuring rapid turnaround times between abnormal imaging and biopsy, and facilitating navigation to genetic counselors, surgical oncologists, and support resources.